United Capital Financial Advisors’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,317
| Closed | -$13.1K | – | 980 |
|
2022
Q4 | $13.1K | Hold |
1,317
| – | – | ﹤0.01% | 1030 |
|
2022
Q3 | $16K | Hold |
1,317
| – | – | ﹤0.01% | 1076 |
|
2022
Q2 | $19K | Buy |
1,317
+67
| +5% | +$967 | ﹤0.01% | 1107 |
|
2022
Q1 | $22K | Hold |
1,250
| – | – | ﹤0.01% | 1145 |
|
2021
Q4 | $30K | Hold |
1,250
| – | – | ﹤0.01% | 1186 |
|
2021
Q3 | $25K | Hold |
1,250
| – | – | ﹤0.01% | 1187 |
|
2021
Q2 | $28K | Buy |
1,250
+237
| +23% | +$5.31K | ﹤0.01% | 1205 |
|
2021
Q1 | $21K | Sell |
1,013
-83
| -8% | -$1.72K | ﹤0.01% | 1174 |
|
2020
Q4 | $18K | Buy |
1,096
+75
| +7% | +$1.23K | ﹤0.01% | 1178 |
|
2020
Q3 | $12K | Hold |
1,021
| – | – | ﹤0.01% | 1143 |
|
2020
Q2 | $12K | Hold |
1,021
| – | – | ﹤0.01% | 1175 |
|
2020
Q1 | $10K | Buy |
1,021
+167
| +20% | +$1.64K | ﹤0.01% | 1169 |
|
2019
Q4 | $8K | Hold |
854
| – | – | ﹤0.01% | 1348 |
|
2019
Q3 | $8K | Hold |
854
| – | – | ﹤0.01% | 1285 |
|
2019
Q2 | $9K | Buy |
+854
| New | +$9K | ﹤0.01% | 1436 |
|